Skip to main content
. 2000 Nov 7;97(23):12776–12781. doi: 10.1073/pnas.97.23.12776

Table 1.

HOX expression in lung cancers by degenerate PCR

HOX DNA control Normal lung GLC20 H187 H460 H661 H1648 H322 H226 H290 H513 H28
A1 11 5 14 24 25
B1 12
C1 3 2 5 4 11
A2 2 3
A3 3 13 4 16 2 34 2 33 2 2 8
B3 1 26 2 4 3 4 3 13 7 6
A4 7 5 4 2 2 14 2 2 3 2
B4 1 2 2
C4 2 24 10 3 2 6 13 9 6
D4 1 2
A5 3 8 2 6 8 2 4
B5 1
A6 1 3
B6 5 16 4 5 11 2
C6/C8 2 2 4 20 10 33 3 7 13 2 6
A7 5 8 31 2 2 11
B7 2 5 2 5 5 8
B8 1 2 4 2 5 3
D8 3 2 4 6 7 3
A9 8 6 10 2 11 2 25
B9 5 19 20 18 17 10 3 2 53
C9 6 2 14 4 5 7 5 3 10 2 3
D9 1 2 2 3
A10 5 13 2 5 29 3 25 25
D10 0 3 2
C12 2 4
D12 0 2
CDX1 1
CDX2 0 2 8
GBX2 4 6 3 2 3 3
Huh15 1 6 2 2 2 5
Huh17 2
Nkx-3.1 1 6
Xlhbox8b 1 2

The percentage of subclones corresponding to each identified HOX locus is listed. The sequence data did not discriminate between HOXC6 and C8, which are listed as C6/C8. The number of clones analyzed from each sample is as follows: DNA control (153), normal lung (62), CLC20-SCLC (48), H187-SCLC (51), H460-large cell (49), H661-large cell (42), H1648-adenocarcinoma (59), H322-bronchioalveolar (55), H226-squamous (36), H290-mesothelioma (61), H513-mesothelioma (44), H28-mesothelioma (36).